Maintenance Therapy in AML: A Trailblazing Slam Dunk, or a Flagrant Fowl. Always a pleasure to hear @ajperissinotti @Berninini. What a lively and engaging debate! #HOPA2025
Epinephrine nasal spray for anaphylaxis now FDA approved.
webmd.com/allergies/news/202…
3
128
The publication on which Blinatumomab received FDA approval for use in consolidation in MRD- ALL is now available! nejm.org/doi/full/10.1056/NE…
2
167
#HOPA Next Big Idea: If anyone is interested in a brainstorming session I'm happy to organize. I especially want my colleagues with smaller networks or internal teams to have an opportunity. @HOPArx
bit.ly/4eCI0X5
4
176
Using the term "non-creative" instead of "palliative" treatment when communicating with patients can help improve communication.
academic.oup.com/oncolo/adva…
FDA approves lifileucel. It's the first CAR-T treatment approved for metastatic melanoma and also the first CAR-T I was able to pronounce on the first attempt. medscape.com/viewarticle/fda… medscape.com/viewarticle/fda…
"Ivosidenib significantly reduced posaconazole and voriconazole levels. Vori should be avoided, empiric high-dose posa (>300 mg/day) may be considered, and therapeutic drug monitoring is recommended in all patients receiving concomitant ivosidenib." @Benyam_Muluneh @KatieBPharmD
FDA approves Omalizumab to reduce accidental food allergies. It's a SQ injection dosed every 2-4 weeks. medscape.com/viewarticle/fda… medscape.com/viewarticle/fda…
2
154
Stephen Clark retweeted
🚨NEW POD ALERT🚨
Burnout and Well-being 🧯
ft. Brent Reed @brentnreed
How did we get here? 🛣️
Prevention v. treatment ⚔️
Work:life balance ⚖️
Foundation of burnout prevention 🏠
5 step process for work design change 🖐️
& more!
pharmacytodose.com/2024/02/0…
open.spotify.com/show/4zYbVR…
podcasts.apple.com/us/podcas…
#PharmICU #Wellbeing #Burnout #TwitteRx #MedTwitter #SoMe #MedEd #FOAMed #FOAMcc #CardioTwitter
Castlemans disease treatment discovered with the help of AI. Too early to tell how effective it is but so far it has helped at one person.
finance.yahoo.com/news/first…
1
2
188
Evaluation of real-world versus clinical trial outcomes of tyrosine kinase inhibitor therapy for chronic myeloid leukemia - Nice work, James B Collins, @Benyam_Muluneh @sarahstump1! 2023 journals.sagepub.com/doi/ful…
8
429
The ACORN investigators leveraged their EHR to enroll patients for clinical trial of cefepime vs pip-tazo. Brilliant execution when speed was essential.
The ACORN study of cefepime vs pip-tazo serves as a great lesson in how to do randomized trials in hospitalized patients.
Now that we have this model, let's do more of this, please!
Here's why it's so important:
blogs.jwatch.org/hiv-id-obse…
6
594
Stephen Clark retweeted
BREAKING NEWS
The 2023 #NobelPrize in Physiology or Medicine has been awarded to Katalin Karikó and Drew Weissman for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19.
Stephen Clark retweeted
So pleased to report that our Mount Sinai-Yale long COVID (MY-LC) paper with @putrinolab & others is now published!! Proud of the hard work of all who contributed. We found biological signatures that can distinguish people with vs. without #longCOVID (1/) nature.com/articles/s41586-0…
Stephen Clark retweeted
Very excited to launch the Yale Center for Infection and Immunity @YaleCII focused on unraveling the disease pathogenesis of post-acute infection syndromes and making effective vaccines to prevent infectious diseases. #longCOVID #MECFS #chronicLyme
yaledailynews.com/blog/2023/…
A fresh perspective on prior auth solutions.
medscape.com/viewarticle/995…















